5 Questions with Romain Clément, Founder & CEO of ArcaScience
In a recent keynote this year, you shared your personal journey as a patient for the first time. Can you…
ArcaScience Raises €6.5M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence
The round was led by The Moon Venture, with participation from Pléiade Venture, Plug and Play Ventures, Bpifrance, and AKKA Technologies. This…
Rethinking Drug Development Decisions: How Advanced Risk – Benefit Models Can Prevent Billion-Dollar Mistakes
Bringing a new drug to market is one of the most ambitious – and riskiest – undertakings in modern science….
Romain Clément Interview: Building ArcaScience to Solve Healthcare’s Biggest R&D Challenge
The pharmaceutical industry faces a sobering reality: 90% of drug candidates fail to reach market, with successful drugs costing an…